2017 annual financial data

China SXT Pharmaceuticals 2017 Financial results

China SXT Pharmaceuticals 2017 financial results with verified reported values.

Direct answer

Revenue was 4,881,523 USD.

Operating income was 1,602,182 USD and net income was 1,185,146 USD.
Operating cash flow was 293,042 USD.

Get free China SXT Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
4,881,523 USD
Operating income
1,602,182 USD
Net income
1,185,146 USD
Operating cash flow
293,042 USD